TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS
First Claim
Patent Images
1. A method of suppressing the proliferation of tumor cells comprising contacting the tumor cells with human placental perfusate cells.
5 Assignments
0 Petitions
Accused Products
Abstract
Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells.
-
Citations
28 Claims
- 1. A method of suppressing the proliferation of tumor cells comprising contacting the tumor cells with human placental perfusate cells.
-
12. A method of suppressing the proliferation of tumor cells comprising contacting the tumor cells with a plurality of CD56+, CD16−
- placental intermediate natural killer (PINK) cells.
- View Dependent Claims (13, 14, 15, 16, 17, 18)
- 19. A method of suppressing the proliferation of tumor cells comprising contacting the tumor cells with combined natural killer cells, wherein said combined natural killer cells comprise natural killer cells isolated from placental perfusate and natural killer cells isolated from umbilical cord blood, and wherein said umbilical cord blood is isolated from the placenta from which said placental perfusate is obtained.
Specification